Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.76 - $2.83 $58,784 - $94,522
33,400 New
33,400 $84,000
Q4 2022

Feb 14, 2023

BUY
$2.05 - $3.47 $85,279 - $144,352
41,600 Added 47.98%
128,300 $322,000
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $44,226 - $383,994
70,200 Added 425.45%
86,700 $251,000
Q2 2022

Aug 15, 2022

BUY
$4.27 - $8.26 $70,455 - $136,290
16,500 New
16,500 $75,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.